Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
BioMed Research International 2014:151479
TB-500 also has anti-apoptotic effects (reducing cell death) and modulates immune cells to limit excessive inflammation and fibrosis
BPC-157 is not FDA-approved for human therapeutic use and is classified as a Category 2 bulk drug substance by the FDA
While both peptides are frequently discussed together and are even available as a BPC 157 + TB 500 blend their mechanisms, primary research areas, and structural profiles are meaningfully distinct
US$ 25.53
US$ 21.78
US$ 23.91
US$ 20.03
US$ 22.62
US$ 28.44
